– Dr. David Sinclair is facing backlash in the longevity community for claims about “reverse aging”
– Sinclair’s claims have led to resignations and criticism from colleagues in the field
– Longevity medicine is attracting billions in investment, with startups focused on studying cellular aging and its cures
Harvard researcher Dr. David Sinclair is facing backlash for claims about “reverse aging” in the longevity community. Sinclair, known for his work in longevity medicine, has attracted criticism from colleagues who argue that his claims are not always backed by sufficient evidence. The controversy escalated when Sinclair’s dog-supplement company issued a press release claiming to have developed a supplement proven to reverse aging in dogs.
Critics, including scientists and researchers, rushed to contest the claim, expressing concerns about the lack of evidence and the implications of selling such products. This controversy led to dozens of scientists resigning from the Academy for Health and Lifespan Research, an organization Sinclair cofounded. Dr. Matt Kaeberlein described Sinclair as a “snake oil salesman” in response to the controversy.
Despite the pushback, Sinclair continues to defend his statements, emphasizing that the supplement only reverses the effects of aging, not aging itself. The concept of reversing aging remains a controversial and challenging topic within the longevity community, with no standardized criteria for measuring or defining aging. Additionally, longevity medicine is a growing field attracting billions in investments from some of the world’s wealthiest executives, indicating that debates about the semantics of aging will likely continue to be relevant in the future.